chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health care professional on 22OCT2003 concerning a 30 year old female vaccinee who experienced redness and swelling at the site of injection one day after receiving Fluvirin on 20OCT2003. On 21OCT2003 the vaccinee experienced redness and swelling at the injection site. The swelling was also reported to be warm to the touch. The vaccinee had not recovered at the time of the report. The was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1 10NOV2003: A follow up report was received from a health care professional indicating that a 31 year old female vaccinee experienced a 50 cents size red sore local reaction one day after receiving Fluvirin on 21OCT2003. The vaccinee recovered on 25OCT2003.
I am coughing more than normal. I cough like 5 good times and stop for 2 hours than I cough again 5, 6 times and again.  Nausea, vomiting, tiredness.
PRESYNCOPE  BP 70 SYSOTLICALLY,   IV  INITIATED AND TAKEN TO EMERGENCY DEPT
Pt. was administered a varicella vaccine at approx 3:00pm. Approx 15 min. after the vaccine, the pt. had vomiting, drowsiness, weakness. Performed BP - 96/60 and O2 sat 88%. Pt. in and out. Dr checked pt. and called ED to admit.
Information has been received from a health professional concerning a patient who was vaccinated with a second dose of Rotateq two weeks late, twelve weeks after the first dose. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Felt ugh, fuzzy headed next day, got chills and had mild fever (99.2), took 2 Tylenol, sucked in couple ColdEeze and felt better within few hours.  Red area on sot arm by that evening - next day (2nd day after shot) developed red rashes by  outside of each breast, larger spot by left side (where shot was given), spot on left side of my neck also.  Not a raised or bumpy rash at all, not sore or itchy.    Called advise nurse to determine taking a benedryl was ok and took one last night.  This morning rash less noticeable but still there - also new little mark on inner left elbow.  Feeling fine this whole time, just concerned because I haven?t read of this reaction much for second Moderna.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine (diptheria orm197 protein) injection) was received from a mother regarding her daughter who developed an injection site reaction characterized by a slight lump and a little redness at the thigh injection site. The patient received the first dose in Sept-2003.  Medical History: Relevant medical history was not provided. Product Details: Indication for Prevnar was immunization. Product was administered in Sep-2003. Dose regimen was 1 dose (intramuscular).  Concomitant Therapy: Concomitant medications were not reported. Event Details: The patient developed an injection site reaction characterized by a slight lump and redness at the thigh injection site (injection site mass) (injection site erythema) in Sep-2003. Related Case(s): HQWYE780802FEB04 and HQWYE824405FEB04. No additional information was available at the date of this report.
Patient entered the room and received vaccines @ 9:10 am. At 9:14am the patient stated he felt dizzy and sweaty. The patient then fell towards the wall, hitting his head, and fell to the floor. The patient was unresponsive for 1-2 minutes and was incontinent of urine. Around 9:23 the patient was able to move from the floor to a seated position and was able to answer questions appropriately. He was alert and oriented x3. Vitals were 144/83, HR 80, temp 99.3. Initial vitals were 139/53 HR of 75 and temp of 98.3. The patient was transported to the emergency department via ambulance for further evaluation.
crying, intractable longer than 4hr p/vax. From additional information received on May 24, 1999, it was reported, "Please note - There is no patient name and any records we have would be in the patient's chart."
Fifteen minutes later began to pass out. Took Benadryl. Slept 12 hours. Two days later also dizzy while walking.
Given Moderna even though under 18 years of age. Patient did not experience any adverse event.
Client received Moderna first dose, then Pfizer second dose. Client reported having received no COVID vaccine before, when getting Pfizer dose.
No arm pain at time of injection; onset of right arm pain and fever greater than 100.  6 hours after administration, took Motrin 400mg with moderate effect.  Continues to complain of arm pain, radiating to consistant 11/24/2003.  Has not taken any pain medication since; spoke to MD 11/15/2003- MD not concerned; no further MD contact since 11/15/2003; unable to determine present pain level; no fever; pain not tender to touch-deep muscular pain; no fever for last 7 days; patient did not miss any work since med administration.  Does not plan to seek further medical follow-up.  Information received via telephone call to client on 11/24/2003.
Patient's arm and shoulder were in pain and discomfort following the injection. Injection site looked to be in the right location. spot patient claimed was the injection site looked like it was scratched and scabbed. The patient stated is hurts more and the pain has lasted longer than the 1st injection. He has an appointment with his doctor to evaluate possible causes but was worried a nerve was poked.
4x5 erythematous, warm to touch, swollen area on arm, had last booster 10 yrs ago
This spontaneous report as received from a Certified Medical Assistant refers to a female patient of unknown age. On 28-MAR-2012 the patient was vaccinated with GARDASIL dose 1. The patient received her second dose of GARDASIL on 30-MAY-2012 and will be receiving her third dose of GARDASIL today, 28-MAY-2013. Dosing information, route of administration and lot numbers were not provided. No adverse effect was reported. Additional information has been requested.
Possible vasovagal response post vaccine.  Client states he has had similar episodes following injections in the past.  Transferred to ED for evaluation and discharged to home
Father states pt ill 24SEP91 to present; fever of 105; not eating, stiffness in legs, unable to walk, vomiting when tried to take liquids; Seen 30SEP91 by pvt MD; 3OCT91 MD noted OM;
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No Treatment medications reported.
Large Red inflamed area on Right upper arm. Second dose of Moderna. After 1st dose noticed arm was hit for 4 days. This time there was swelling, redness and warmth. To: Advil, Tylenol and cool compresses.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021 at 1:27 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Oct-2021 at 1:27 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter  The Excursion duration was reported as 1 month.  No treatment medication was provided by the reporter.
Angioedema on 3-26-15 upon waking; epinephrine prednisone and Benadryl. Has had 3 more reactions 3-28-15 lip swelling, 3-30-15 lip and eye swelling upon waking, and 3-31-15 hives upon waking; all treated with Benadryl.
VISUAL DISTURBANCE; COMPLEX MIGRAINE; HAD DIFFICULTY FINDING WORDS; NOT FEELING NORMAL; FATIGUE; COMPLEX HEADACHES; CHILLS; BODY ACHES; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no previous history of migraines. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced visual disturbance. On 13-APR-2021, the subject experienced complex migraine. On 13-APR-2021, the subject experienced had difficulty finding words. On 13-APR-2021, the subject experienced not feeling normal. On 13-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced complex headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from visual disturbance, complex migraine, and had difficulty finding words, and body aches, and chills on 13-APR-2021, had not recovered from fatigue, and not feeling normal, and the outcome of complex headaches was not reported. This report was non-serious.; Sender's Comments: V0:Medical assessment comment not required as per standard operating procedures, as the case was assessed as non-serious.
POST VACCINE, C/O CRAMPING IN LEGS AND ARMS, REPORTS DID NOT EAT OR DRINK WATER ALL DAY, GIVEN COLD WATER AND CRACKERS. VSS. ESCORTED TO EXIT WITH NO ISSUES ONCE S/S RESOLVED AT 1530.  1519 BP 119/81 HR 81 SATS 97% RA 1529 STANDING BP 119/81 HR 83 SATS 97% RA
HEADACHE; FEELING UNWELL; FEVER; FEELING SLUGGISH; VOMITED; EXCESSIVE THIRST; BODY ACHES; ARM SORENESS/ARM ACHES; This spontaneous report received from a patient concerned a 54 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: not reported) dose was not reported, administered on 05-APR-2021 15:15 to left arm for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced body aches. On 05-APR-2021, the subject experienced arm soreness/arm aches. On 06-APR-2021, the subject experienced feeling sluggish. On 06-APR-2021, the subject experienced vomited. On 06-APR-2021, the subject experienced excessive thirst. On 06-APR-2021, the subject experienced feeling unwell. On 06-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.2 (units unspecified). On an unspecified date, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache, and had not recovered from feeling sluggish, arm soreness/arm aches, excessive thirst, fever, vomited, feeling unwell, and body aches. This report was non-serious.
Initial symptoms were severe headache, fever, chills, nausea, muscle aches, heat redness and swelling at injection site. Most of these lasted ~24 hours. Rash running down the arm started at ~36 hours and continued for 5 days.  A week after receiving the vaccine, I was exposed to COVID and was moderately ill for 15 days.  I had been exposed numerous times throughout the pandemic and never developed symptoms or tested positive. I believe the Shingrix reaction opened the door to the COVID illness.
Received 0.5ml instead of 0.25ml for booster; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Received 0.5ml instead of 0.25ml for booster) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 28-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Received 0.5ml instead of 0.25ml for booster). On 28-Oct-2021, ACCIDENTAL OVERDOSE (Received 0.5ml instead of 0.25ml for booster) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-367465 (Patient Link).
Patient died 10/07/2021 at SNF after testing positive for COVID19 10/06/2021. Family elected for comfort measures after COVId19 diagnosis due to other ongoing medical issues.
This spontaneous report was received from a Licensed Practical Nurse refers to a 19 years old male patient. On 23-NOV-2010 the patient was vaccinated with a 0.5 ml dose of VAQTA ("25/0.5 U/ml" as reported) (lot # unspecified) intramuscular (location and indication unspecified). The nurse reported that on 23-JUL-2013 the patient was inadvertently administered a pediatric dose of VAQTA. No adverse effects reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Patient describes one to one-and-a-half week of nausea and right arm numbness.
(per mother) "very ill with nausea".  She became white from head to toe and having muscle spasms and hands were doing this (mother acting out hand movements that were spastic and contortion like). "thought she was having a stroke".
(R) arm area of redness, warmth, pain, fever to 103 degrees - Lasted X 3-4 days.
p/school noted itchiness of scalp; devel hives-scalp, face, torso-entire body; began as discrete hives & rapidly became confluent; no wheezing or dyspnea; treated w/OTC DPH; MD uncertain as to cause still has some hives 5APR93
My left side was tingling; This case was reported by a consumer via (Shingrix) interactive digital media and described the occurrence of tingling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced tingling. On an unknown date, the outcome of the tingling was unknown.   It was unknown if the reporter considered the tingling to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient had received dose of shingrix and 2 weeks later experienced tingling on left side. The patient was asking about to take the 2nd dose.
16 yo with no significant PMH who developed right-sided CN7 palsy about 7 days after receiving second Pfizer COVID vaccination.  Facial weakness preceded by slight aching pain behind R ear in region of mastoid. No pain, rash, changes to taste or hearing, no other weakness or sensory changes. Received prednisone taper per primary care physician with some improvement in symptoms over a week. At time of evaluation she reported that her weakness had significantly improved.
thirty minutes after the shot was administered on Wednesday my arm began to itch. I hadn't been outside in a while due to quarantining so I assumed it was my allergies as the pollen is awful right now. That same evening my arm began to heat up and the pain began to set in. It hurt to even type. I had difficulty lifting my arm. Also, it felt like it was on fire. I thought it was an internal thing, but it was also hot to the touch. The following day (Thurs) I developed a bruise - small bluish purplish bruise a few inches down from where the shot was administered. Later that day, a big red, raised circle developed as well. So, on Thursday, I still had the horrible itching, i could barely move arm because of the pain, my arm was hot, i had a bruise and a raised red circle, none of this at the injection site, but a few inches down from it. I was also tired. All of these symptoms continued and worsened through Saturday. By Sunday, i still had the same symptoms, but they stopped getting worse. On Monday, i only had a small bruise and a little redness, some fatigue, but not much. Everything else was gone. However, today, Thursday, April 15th, I woke up to itching again. This time at the injection site. A rash is developing where the shot was administered and my arm is heating up again. The rash itches as if I rolled around in grass, it feels like one of my allergic reaction rashes or similar to hives. It doesn't look like hives, it looks like a rash, but the itching feels like hives.
muscle aches, headache, fatigue, nausea, dizzy/woozy. Began 1/23 and have not resolved. They have actually been getting worse
03/13/2021 I began to tingle in my fingers and feet. followed by  numbness in legs and arms-gradually everyday, to the point where I could not stand or walk. It made me relapse on my CIDP.
experienced side effects after receiving the first two doses; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (experienced side effects after receiving the first two doses) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (experienced side effects after receiving the first two doses). At the time of the report, IMMUNISATION REACTION (experienced side effects after receiving the first two doses) outcome was unknown. Not Provided          No concomitant medications were reported.   No treatment details were reported.
Pt came into pharmacy today and said her arm was still sore and asked what size needle was used. I said 5/8" subcutaneous injection.
This spontaneous report was received from a nurse concerning a 4 months old patient of unknown gender. There was no information about the patient's medical history, concurrent conditions and concomitant therapies. On 09-JAN-2017, the patient was vaccinated with improperly stored doses of ROTATEQ orally from lot number M031650 with expiration date of 16-MAR-2018 (strength, dosage schedule, anatomical location and route of administration were not provided) for prophylaxis. The administered doses were exposed to a temperature higher than 8°C but lower than 25°C for 1 hour and 20 minutes determined using digital data logger. The vaccine had no previous temperature excursion. The nurse reported that a possible cause for the temperature excursions was the action of the auto defrost cycle of the refrigerator. They had ordered a commercial unit to eliminate this issue. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA009503: US-009507513-1701USA009504: US-009507513-1701USA008111.
Patient in 3 - 7 days post vaccination has had fevers from 101.5 - 103, treated with Ibuprofen. Patient currently has 3 "pocks" and 5 spots that appear as if they will turn into pocks.
Fever, chills, muscle aches, extreme fatigue.  I took some Tylenol and went to bed.
Dose 1 - No problems. Dose 2 - 1 hour after the dose painful tingling (paraesthesia) in knuckles of left hand and around left ankle.  Later on spread to right hand and right foot.   Tingling (sometimes painful) in hands and feet has continued for 4 weeks (today is 4-23-2021).  Mainly in right hand.  Sometimes a few other random locations.
After receiving 2nd dose / sensitivity in chest area; This case was reported by a consumer and described the occurrence of increased skin sensitivity in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2021, the patient received the 2nd dose of Shingrix. In January 2021, less than 2 weeks after receiving Shingrix, the patient experienced increased skin sensitivity. On an unknown date, the outcome of the increased skin sensitivity was unknown.   It was unknown if the reporter considered the increased skin sensitivity to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and experiencing sensitivity in chest area.
Pt had received Hep A&B vaccine on 03/16/2021 less than 14 days prior to receiving the Hanssen COVID 19 vaccine. No known adverse side effects.
Lost his bowels; Heavy breathing; Sore Throat; The chills; Fever; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Down's syndrome. Concomitant products included AMBRISENTAN (LETAIRIS), TADALAFIL (ADCIRCA), ALLOPURINOL, LEVOTHYROXINE, OMEPRAZOLE and SPIRONOLACTONE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other relevant medication history included vitamin D.